• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHREX, INC. UNIVERSAL GLENOID - BASEPLATE MEDIUM; SHOULDER PROSTHESIS, REVERSE CONFIGURATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHREX, INC. UNIVERSAL GLENOID - BASEPLATE MEDIUM; SHOULDER PROSTHESIS, REVERSE CONFIGURATION Back to Search Results
Model Number UNIVERSAL GLENOID - BASEPLATE MEDIUM
Device Problems Detachment of Device or Device Component (2907); Appropriate Term/Code Not Available (3191)
Patient Problem Ambulation Difficulties (2544)
Event Date 09/20/2019
Event Type  Injury  
Manufacturer Narrative
The contribution of the device to the reported event could not be determined as the device was not returned for evaluation.It was reported that the facility is not releasing the device.The root cause of the event could not be determined from the information available and without device evaluation.
 
Event Description
It was reported the patient had a primary reverse total shoulder procedure on (b)(6) 2019.The patient returned to the or for a revision procedure on (b)(6) 2019 due to the implanted glenosphere disassociating from the baseplate.During the original procedure, the central screw depth gauge was used to ensure that the central screw was fully seated.After glenosphere impaction, the glenosphere forceps were used in multiple planes to ensure engagement of the morse taper.During the revision procedure the original glenosphere (ar-9120-02 / lot: 18.01057) and baseplate (ar-9504l-04 / lot: 18.00719) were explanted, and the surgeon implanted a mgs baseplate (ar-9560-28-2 / lot: 5642) and glenosphere (ar-9564-2842-lat / lot: 18.00802) in its place.The primary and revision procedure were performed by the same surgeon, and took place at the same facility.The following arthrex parts were implanted during the primary procedure: ar-9120-02 // lot: 18.01057 // qty.: 1, ar-9145-24 // lot: 18.00674 // qty.: 1, ar-9145-30 // lot: 18.01275 // qty.: 1, ar-9165-20nl // lot: 10247862 // qty.: 1, ar-9501-12p // lot: 18.00906 // qty/: 1, ar-9502f-42cpc // lot: 160037703 // qty.: 1, ar-9503l-03c // lot: 150044008 // qty.: 1, ar-9504l-04 // lot: 18.00719 // qty.: 1, ar-9550-06 // lot: 18.00623 // qty.: 1.The following arthrex parts were implanted during the revision procedure: ar-9503l-03c // lot: 18.00561 // qty.: 1, ar-9550-06 // lot: 18.00990 // qty.: 1, ar-9560-28-2 // lot: 5642 // qty.: 1, ar-9561-30s // lot: 6227 // qty.: 1, ar-9563-16 // lot: 2019000253 // qty.: 2, ar-9563-24 // lot: 2019001686 // qty.: 1, ar-9563-28 // lot: 2019001343 // qty.: 1, ar-9564-2842-lat // lot: 18.00802 // qty.: 1.Additional information received on 10/08/219: the rep reported the disassociation was first discovered from x-rays taken during an office visit on (b)(6) 2019.The rep is following up with the surgeon to discuss if the cause of the disassociation is known.The bone quality was hard.The rep stated the explanted devices were sent to pathology, and will not be returning to arthrex for evaluation.The following list is all of the arthrex parts that were explanted during the revision procedure: ar-9120-02 // lot: 18.01057, ar-9504l-04 // lot: 18.00719, ar-9145-24 // lot 18.00674, ar-9145-30 // lot 18.01275, ar-9165-20nl // lot 10247862, ar-9503l-03c // lot 150044008, ar-9550-06 // lot 18.00623.Additional information received on 10/09/2019: the rep confirmed no explanted implants have been discarded; rather, they have been sent to pathology.The rep has requested that the facility not discard the devices after the required 30 day hold.However, per the facility's policy the implants cannot be released without written consent from the patient.The request for the patient's consent to release the explanted devices will be introduced to the patient at their next follow-up visit which will take place in approximately four weeks.It was reported prior to the revision procedure and disassociation discovery the patient was experiencing a loss of mobility.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNIVERSAL GLENOID - BASEPLATE MEDIUM
Type of Device
SHOULDER PROSTHESIS, REVERSE CONFIGURATION
Manufacturer (Section D)
ARTHREX, INC.
1370 creekside boulevard
naples FL 34108 1945
Manufacturer (Section G)
ARTHREX, INC.
1370 creekside boulevard
naples FL 34108 1945
Manufacturer Contact
vik bajnath
8009337001
MDR Report Key9254820
MDR Text Key169236410
Report Number1220246-2019-01378
Device Sequence Number1
Product Code PHX
UDI-Device Identifier00888867057357
UDI-Public00888867057357
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142863
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Administrator/Supervisor
Type of Report Initial
Report Date 10/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2023
Device Model NumberUNIVERSAL GLENOID - BASEPLATE MEDIUM
Device Catalogue NumberAR-9120-02
Device Lot Number18.01057
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/07/2019
Initial Date FDA Received10/30/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-